Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C K TASHIMA

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
American Journal of Clinical Pathology|March 1, 1980
Carcinoembryonic antigen levels in malignant pleural fluids obtained from patients with mammary cancerA DiStefano, C K Tashima, H A Fritsche, et al.
Cancer Research|August 1, 1976
Reduction of ifosfamide toxicity using dose fractionationV Rodriguez, G P Bodey, E J Freireich, et al.
Cancer Treatment Reports|February 1, 1980
Vinblastine given as a continuous 5-day infusion in the treatment of refractory advanced breast cancerH Y Yap, G R Blumenschein, M J Keating, et al.
Cancer|July 1, 1979
Combination chemotherapy with vincristine and methotrexate for advanced refractory breast cancerH Y Yap, G R Blumenschein, C K Tashima, et al.
Cancer|April 1, 1978
Adriamycin and 1-(2-chlorethyl)-3-cyclohexyl-1-nitrosourea (CCNU) in the treatment of metastatic breast cancerW C Waterfield, C K Tashima, G N Hortobagyi, et al.
Cancer|January 15, 1980
Pulmonary toxicity of mitomycinA U Buzdar, S S Legha, M A Luna, et al.
Cancer Treatment Reports|March 1, 1978
Phase II study of cis-dichlorodiammineplatinum(II) in advanced breast cancerH Y Yap, P Salem, G N Hortobagyi, et al.
Cancer Treatment Reports|November 1, 1978
Response of disseminated breast cancer to combined modality treatment with chemotherapy and levamisole with or without Bacillus Calmette-GuérinG N Hortobagyi, H Y Yap, G R Blumenschein, et al.
Cancer Treatment Reports|January 1, 1979
Phase II study with sequential L-asparaginase and methotrexate in advanced refractory breast cancerH Y Yap, R S Benjamin, G R Blumenschein, et al.
Cancer Treatment Reports|July 1, 1978
Adriamycin and mitomycin C: possible synergistic cardiotoxicityA U Buzdar, S S Legha, C K Tashima, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
American Journal of Clinical Pathology|March 1, 1980
Carcinoembryonic antigen levels in malignant pleural fluids obtained from patients with mammary cancerA DiStefano, C K Tashima, H A Fritsche, et al.
Cancer Research|August 1, 1976
Reduction of ifosfamide toxicity using dose fractionationV Rodriguez, G P Bodey, E J Freireich, et al.
Cancer Treatment Reports|February 1, 1980
Vinblastine given as a continuous 5-day infusion in the treatment of refractory advanced breast cancerH Y Yap, G R Blumenschein, M J Keating, et al.
Cancer|July 1, 1979
Combination chemotherapy with vincristine and methotrexate for advanced refractory breast cancerH Y Yap, G R Blumenschein, C K Tashima, et al.
Cancer|April 1, 1978
Adriamycin and 1-(2-chlorethyl)-3-cyclohexyl-1-nitrosourea (CCNU) in the treatment of metastatic breast cancerW C Waterfield, C K Tashima, G N Hortobagyi, et al.
Cancer|January 15, 1980
Pulmonary toxicity of mitomycinA U Buzdar, S S Legha, M A Luna, et al.
Cancer Treatment Reports|March 1, 1978
Phase II study of cis-dichlorodiammineplatinum(II) in advanced breast cancerH Y Yap, P Salem, G N Hortobagyi, et al.
Cancer Treatment Reports|November 1, 1978
Response of disseminated breast cancer to combined modality treatment with chemotherapy and levamisole with or without Bacillus Calmette-GuérinG N Hortobagyi, H Y Yap, G R Blumenschein, et al.
Cancer Treatment Reports|January 1, 1979
Phase II study with sequential L-asparaginase and methotrexate in advanced refractory breast cancerH Y Yap, R S Benjamin, G R Blumenschein, et al.
Cancer Treatment Reports|July 1, 1978
Adriamycin and mitomycin C: possible synergistic cardiotoxicityA U Buzdar, S S Legha, C K Tashima, et al.
Pageof 4